Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.
A structurally novel set of inhibitors of bacterial type II topoisomerases with potent in vitro and in vivo antibacterial activity was developed. Dual-targeting ability, hERG inhibition, and pharmacokinetic properties were also assessed.